NFE2L2 and acute myeloid leukemia: In contrast, the present study demonstrated that treatment with both AZD0364 and ZSTK474 enhanced ROS production resulting in the increase of NF-κB and NRF2/HO-1 pathway proteins in AML MOLM-14 cells.